Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 9 results:
Author Title [ Type(Desc)] Year
Filters: Author is Bouganim, N.  [Clear All Filters]
Journal Article
F. Khosrow-Khavar, Filion, K. B., Bouganim, N., Suissa, S., and Azoulay, L., Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study, Circulation, vol. 141, pp. 549-559, 2020.
F. Khosrow-Khavar, Yin, H., Barkun, A., Bouganim, N., and Azoulay, L., Aromatase inhibitors and the risk of colorectal cancer in postmenopausal women with breast cancer, Ann Oncol, vol. 29, pp. 744-748, 2018.
S. Couraud, Dell'Aniello, S., Bouganim, N., and Azoulay, L., Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia, Breast Cancer Res Treat, vol. 146, pp. 619-26, 2014.
F. Khosrow-Khavar, Bouganim, N., Filion, K. B., Suissa, S., and Azoulay, L., Cardiotoxicity of Sequential Aromatase Inhibitors Use in Women with Breast Cancer, Am J Epidemiol, 2020.
D. Abrahami, Douros, A., Yin, H., Yu, O. H., Faillie, J. L., Montastruc, F., Platt, R. W., Bouganim, N., and Azoulay, L., Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study, Bmj, vol. 363, p. k4880, 2018.
J. Rouette, Yin, H., Yu, O. H. Y., Bouganim, N., Platt, R. W., and Azoulay, L., Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes, Diabet Med, 2020.
L. Azoulay, Soldera, S., Yin, H., and Bouganim, N., Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study, Epidemiology, vol. 27, pp. 594-601, 2016.
V. Mandilaras, Bouganim, N., Yin, H., Asselah, J., and Azoulay, L., The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer, Br J Cancer, vol. 116, pp. 103-108, 2017.
C. Santella, Yin, H., Hicks, B. M., Yu, O. H. Y., Bouganim, N., and Azoulay, L., Weight-lowering effects of glucagon-like peptide-1 receptor agonists and detection of breast cancer among obese women with diabetes, Epidemiology, 2020.
[Page last reviewed 6 April 2021]